BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11746184)

  • 1. Succimer treatment during ongoing lead exposure reduces tissue lead in suckling rats.
    Varnai VM; Piasek M; Blanusa M; Sarić MM; Kostial K
    J Appl Toxicol; 2001; 21(5):415-6. PubMed ID: 11746184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined chelation therapy in reducing tissue lead concentrations in suckling rats.
    Kostial K; Blanusa M; Piasek M; Restek-Samarzija N; Jones MM; Singh PK
    J Appl Toxicol; 1999; 19(3):143-7. PubMed ID: 10362263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succimer treatment and calcium supplementation reduce tissue lead in suckling rats.
    Marija Varnai V; Piasek M; Blanusa M; Matek Sarić M; Juresa D; Kostial K
    J Appl Toxicol; 2004; 24(2):123-8. PubMed ID: 15052607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbic acid supplementation does not improve efficacy of meso-dimercaptosuccinic acid treatment in lead-exposed suckling rats.
    Varnai VM; Piasek M; Blanusa M; Juresa D; Sarić M; Kostial K
    Pharmacol Toxicol; 2003 Oct; 93(4):180-5. PubMed ID: 14629742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of lead retention by mono-3-methylbutan-1-yl meso-2,3-dimercaptosuccinate in suckling rats.
    Blanusa M; Kostial K; Piasek M; Jones MM; Singh PK
    Analyst; 1995 Mar; 120(3):951-3. PubMed ID: 7741262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
    Cory-Slechta DA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial role of monoesters of meso-2,3-dimercaptosuccinic acid in the mobilization of lead and recovery of tissue oxidative injury in rats.
    Saxena G; Pathak U; Flora SJ
    Toxicology; 2005 Oct; 214(1-2):39-56. PubMed ID: 16019123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication.
    Flora SJ; Pande M; Mehta A
    Chem Biol Interact; 2003 Jun; 145(3):267-80. PubMed ID: 12732454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined early treatment with chelating agents DMSA and CaDTPA in acute oral cadmium exposure.
    Sarić MM; Blanusa M; Juresa D; Sarić M; Varnai VM; Kostial K
    Basic Clin Pharmacol Toxicol; 2004 Mar; 94(3):119-23. PubMed ID: 15049341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chelate treatments on kidney, bone and brain lead levels of lead-intoxicated mice.
    Jones MM; Basinger MA; Gale GR; Atkins LM; Smith AB; Stone A
    Toxicology; 1994 Apr; 89(2):91-100. PubMed ID: 8197593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Environ Health Perspect; 2001 Jun; 109(6):613-9. PubMed ID: 11445516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged oral treatment with two monoesters of meso-2,3-dimercaptosuccinic acid for depleting inorganic mercury retention in suckling rats.
    Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK
    Pharmacol Toxicol; 1995 Sep; 77(3):216-8. PubMed ID: 8884886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
    Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
    Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 and Bcl2 apoptosis proteins in meso-2,3-dimercaptosuccinic acid treated lead-intoxicated rabbits.
    Tousson E; Rafat BM; Hessien M; El Barbary AA; Sami A
    Toxicol Ind Health; 2011 Apr; 27(3):271-8. PubMed ID: 21112928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined administration of taurine and meso 2,3-dimercaptosuccinic acid in the treatment of chronic lead intoxication in rats.
    Flora SJ; Pande M; Bhadauria S; Kannan GM
    Hum Exp Toxicol; 2004 Apr; 23(4):157-66. PubMed ID: 15171566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two heavy metal chelators for treatment of lead toxicosis in cockatiels.
    Denver MC; Tell LA; Galey FD; Trupkiewicz JG; Kass PH
    Am J Vet Res; 2000 Aug; 61(8):935-40. PubMed ID: 10951987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of calcium disodium EDTA and meso-2,3-dimercaptosuccinic acid on tissue concentrations of lead for use in treatment of calves with experimentally induced lead toxicosis.
    Meldrum JB; Ko KW
    Am J Vet Res; 2003 Jun; 64(6):672-6. PubMed ID: 12828250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral treatment of avian lead intoxication with meso-2,3-dimercaptosuccinic acid.
    Hoogesteijn AL; Raphael BL; Calle P; Cook R; Kollias G
    J Zoo Wildl Med; 2003 Mar; 34(1):82-7. PubMed ID: 12723805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.